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ABSTRACT
Introduction: Curcumin, a natural compound present in turmeric (Curcuma longa) has
been known to possess both anti-inflammatory and antioxidant effects.  Objectives: The
objectives of the study were to evaluate the cytotoxic activities and to determine the mode
of cell death induced by curcumin towards the human mammary carcinoma cells (MDA-
MB-231).  Methodology: Cytotoxicity of curcumin and its effect on cell viability were
determined by using MTT assay and trypan blue dye exclusion method, respectively.  The
mode of cell death was detected by viewing under a light microscope and through DNA
fragmentation analysis.  Results and discussion: Curcumin was cytotoxic to MDA-MB-
231 cells with the IC
50 
of 17.25 ì g/ml.  Cell viability treatment using curcumin at
concentrations of 30 ì g/ml and 10 ì g/ml was significantly (p<0.05) reduced at 48 and 56
hours, respectively,  compared to the control.  Cells treated with curcumin (30, 10, 3, and
1ì g/ml) showed apoptotic features such as shrinkage of cell, membrane blebbing, chromatin
condensation and nuclear fragmentation under a light microscope.  DNA extracted from
cells treated with curcumin at all concentrations were intact after 24 hours but fragmented
after 72 hours, forming DNA laddering on agarose gel, a  hallmark of apoptosis.  Conclusion:
Induction of apoptosis in breast cancer cells by curcumin suggests its potential use as a
strategy for  cancer control.
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INTRODUCTION
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6- heptadiene-3,5-di-one], with molecular
chemical formula of C
21
H
20
O
6
 is the major constituent and  active ingredient of Curcuma
longa (turmeric), a plant which belongs to the Zingiberaceae.  Curcumin belongs to the
class of curcuminoids.[1]
Chemical structure of curcumin
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Curcumin exhibits a broad spectrum of effects, including anti-inflammatory, anti-
mutagenic, anti-proliferative, and anti-carcinogenic activities.[2]  Curcumin has been shown
to chemoprevent carcinogenesis [3] and inhibit the growth and metastasis of tumour cells.[4]
Exposure of tumour cell lines to curcumin in vitro has resulted in inhibition of cell
proliferation or induction of apoptotic cell death.[5]  In a previous report, curcumin was
shown to inhibit the proliferation and cell cycle progression of human umbilical vein
endothelial cells.[6]
The objective of the study was to determine the in vitro cytotoxic properties and mode
of cell death of curcumin towards the human mammary carcinoma (MDA-MB-231) cells.
MATERIALS AND METHODS
Compound
Curcumin was  supplied by the Department of Chemistry, Faculty of Sciences, Universiti
Putra Malaysia. The compound was dissolved in dimethylsulfoxide (DMSO) to give a
stock concentration of 10 mg/ml.
Cells
The human mammary carcinoma (MDA-MB-231), acute myeloblastic leukemia (HL-60),
breast adenocarcinoma (MCF-7), ovarian cancer (CaOV3), cervical epithelial carcinoma
(HeLa) and Chinese hamster ovary (CHO) cell lines were purchased from the American
Type of Culture Collection (ATCC), USA.  The cells were grown in RPMI 1640 medium
supplemented with 10% of  fetal calf serum and antibiotics (100 IU of penicillin/100 mg/ml of
streptomycin).  The cells were maintained in a 25 cm2 T-flask and incubated at 37ºC under
5% CO
2
 in a humidified atmosphere.  Cell viability was measured by staining the cells with
trypan blue and counted in a hemocytometer under a light microscope.
Determination of Cytotoxicity (MTT Assay)
Cytotoxicity assay was performed in a 96-well microtitration plate.  The cells at an initial
concentration of 1 x 106 cells/ml were treated with 30, 10, 3, 1, 0.3, 0.1 and 0.03 μg/ml of
curcumin.  Initially, various concentrations of the compound were prepared from the substock
solution by serial dilution in RPMI 1640 to give a volume of 100 μl in each of the microtiter-
plate wells.  Subsequently, 100 μ l of the cell suspension was added into each well.  Control
without the compound was included.  The assay was performed in triplicate.  The plates
were then incubated at 37ºC, 5% CO
2
, 90% humidity for 72 hours.
Cytotoxicity of curcumin was quantitatively estimated by a non-radioactive, colorimetric
assay system using tetrazolium salt, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenil-
tetrazolium bromide.  Briefly, MTT was dissolved in phosphate buffered saline at 5 mg/ml
and filter-sterilised to remove a small amount of insoluble residue present in some batches
of MTT.  The MTT solution was added directly to all appropriate microtitre-plate wells (10
μl per 100 μl medium) containing cells, complete growth medium with or without the tested
compound.  The plate was then incubated for 4 hours at 37ºC to allow MTT metabolism to
formazan.  Subsequently, the supernatant was aspirated and 100 μ l of DMSO was added
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and mixed thoroughly to dissolve the dark blue formazan crystals.  Optical density (OD)
was measured on an automated spectrophotometric EL 340 multiplate reader (Bio-Tek
Instruments Inc., USA) using the test and reference wavelength of 570 and 630 nm,
respectively.  The cytotoxic concentration/dose that killed cells by 50% (IC
50
) was determined
from absorbance (OD) versus concentration curve.
Determination of Cell Viability
The MDA-MB-123 cells with a density of 1 x 105 cells/ml were treated with 30, 10, 3 and 1 μg/
ml of curcumin.  Control (untreated cells) was included.  The cells were harvested  every 8
hours for 3 days (72 hours) and  viability was measured by staining the cells with 0.25%
trypan blue at a dilution of 1:1, and counted in a hemocytometer under a light microscope.
The dead cells were stained blue while  the viable cells remained clear.  The percentage of
cell viability can be calculated using the  formula:
Percentage of viability = number of viable cells/total cell number x 100
Determination of Morphological Changes
The untreated and curcumin-treated MDA-MB-123 cells (30, 10, 3 and 1 μg/ml) for 24 and 72
hours were viewed under an inverted light microscope.  Apoptotic characteristics were
identified by the appearance of cell shrinkage, nuclear condensation, and/or the presence
of membrane-bound apoptotic bodies.  Necrotic characteristics were identified by the
appearance of irregular clumping of chromatin, swelling of all cytoplasmic compartments
and focal disruption of membranes.
Determination of Mode of Cell Death (DNA Fragmentation Analysis)
DNA from the untreated and curcumin-treated MDA-MB-123 cells (30, 10, 3 and 1 μg/ml) for
24 and 72 hours were isolated using the Apoptotic DNA Ladder Detection Kit (Chemicon,
USA) and the manufacturer’s established methods.  Agarose gel electrophoresis was carried
out for the analysis of fragmentation of DNA.  GeneRulerTM 100 bp DNA Ladder Plus was
used as a marker for size comparison.  The agarose gel was then stained with ethidium
bromide and DNA was visualised by UV illumination.
RESULTS
Cytotoxicity of Curcumin
The cytotoxic effects of curcumin were evaluated against a panel of cancerous cell lines
inclusive of the human mammary carcinoma (MDA-MB-231), acute myeloblastic leukemia
(HL-60), breast adenocarcinoma (MCF-7), ovarian cancer (CaOV3) and cervical epithelial
carcinoma (HeLa) by using the MTT assay.  Chinese hamster ovary (CHO) cell line was
used as a representative of a  normal cell line.  Curcumin was found to be most cytotoxic to
the human mammary carcinoma (MDA-MB-231) with the IC
50
 value (a concentration that
reduces the cell number to 50% as compared to the untreated value) at 17.25 ì g/ml (Table 1).
Malaysian Journal of Medicine and Health Sciences Vol. 2(2) June 2006
 74   SY Latifah, HA Faujan, LP Sze, AR Raha, AH Hisyam & OC Li
Table 1.  Cytotoxicity of curcumin against canceous and non-cancerous cell lines based on the
IC
50 
value determined by the MTT assay
Cell line IC
50
 (ì g/ml)
Human mammary carcinoma (MDA-MB-231) 17.25
Human cervical epithelial carcinoma (HeLa) 27.81
Human breast adenocarcinoma (MCF-7) >30
Human ovarian cancer (CaOV3) >30
Human acute myeloblastic leukemia (HL-60) >30
Chinese hamster ovary (CHO) >30
Effects of Curcumin on Cell Viability of MDA-MD-231 Cells
The viability of cells treated with 30 and 10 ì g/ml of curcumin was significantly reduced
(p<0.05) at 48 and 56 hours, respectively, compared to the control.  There was a reduction,
but not significant, in cell viability of treatments of lower concentrations of the compound
(3 and 1 ì g/ml) (Fig. 1).
Figure 1. Effects of curcumin on cell viability. Cell viability was measured by staining the cell with
trypan blue and counting in a haemocytometer under a light microscope. Results are
expressed as mean ± SEM in triplicate determination. Differences between the treated
and control were determined by the Independent-sample T-test.
* p < 0.05
Effects of Curcumin on Cell Morphology in MDA-MD-231 Cells
Unaffected normal viable MDA-MB-231cells were fibroblast-like and were attached to the
surface of the flask. The dead cells were detached from the surface and appeared oval or
round in shape. They exhibited a few morphological features characteristic of apoptosis
such as nuclear compaction, cytoplasmic constriction and a reduction in cell volume,
membrane blebbing, and formation of apoptotic bodies.  Necrotic cells were not observed
(Fig. 2).  The number of cells of all the treated groups was obviously fewer than the control.
The numberof non-viable cells was prominent in the treatment of the highest
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Figure 2. Effects of different concentrations of curcumin on morphology of MDA-MB-231 cells
after 24 hours.  Dead cells were rounded (rc) and detached from surface of the flask (dc).
They exhibited some features of apoptosis such as nuclear condensation (nc), membrane
blebbing (mb), cell shinkage (cs) and formation of apoptotic bodies (ab).  The unaffected
healthy fibroblast-like cells (fc) remained attached (ac) to the surface of the flask (200X
magnification).
of the highest concentration of curcumin (30 ì g/ml).  In general, the number of attached
cells (normal viable healthy cells) decreased as the concentration of the compound increased
(Fig. 3).c
nc
mb
ab dc. rc. cs
30 ì g/ml 10 ì g/ml
3 ì g/ml 1ì g/ml
ab
mb
Control
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Figure 3. Effects of different concentrations of curcumin on morphology of MDA-MB-231 cells
for 72 hours.  The majority of the cells at treatment of 30 and 10 ì g/ml of curcumin
underwent secondary necrosis (sn).  Cell density decreased with the increase in concentration
of curcumin.  Number of attached fibroblast-like cells (ac) was fewer in the treated cells
compared to the control (100X magnification).
Effects of Curcumin on DNA Fragmentation in MDA-MD-231 Cells
DNA patterns of the curcumin-treated and untreated cells were observed by the DNA
fragmentation analysis.  DNA from cells treated with all concentrations of the compound
(30, 10, 3 and 1 ì g/ml) was intact after 24 hours (data not shown).  After 72 hours, distinctive
ladder-like pattern of DNA due to fragmentation that produced multiples of 200 base pairs
was clearly observed on the agarose gel from treatments using 30, 10 and 3 ì g/ml of curcumin.
Slight DNA degradation was observed from treatment of 1 ìg/ml of curcumin.  DNA from
the control remained intact (Fig. 4).
control
ac
3 ì g/ml 1 ì g/ml
ac
10 ì g/ml
sn
30 ì g/ml
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Figure 4. Effects of different concentrations of curcumin on DNA of MDA-MB-231 cells for 72
hours.  The distinctive ladder-like pattern was observed from treatments of 30, 10 and 3
ì g/ml of curcumin.  DNA of the control was intact.  Lane M: Marker (HindIII digest of
lambda DNA).
DISCUSSION
Curcumin was cytotoxic to a few cancerous cell lines used in the study.  The human mammary
carcinoma cell line (MDA-MB-231) was found to be most sensitive towards curcumin with
the IC
50
 value of 17.25 ì g/ml (Table 1).  The compound has been shown previously to be
cytotoxic to  some of the cell lines used in this study such as acute myeloblastic leukemia
(HL-60), breast adenocarcinoma (MCF-7) and cervical epithelial carcinoma (HeLa), and also
to chronic myelogenic leukemia (K-562). [7]   Nevertheless, the response was quite different
from our findings, whereby curcumin was indicated to be most cytotoxic towards HL-60, K-
562 and MCF-7 but did not show much activity in HeLa cells.  This is possibly due to batch-
to-batch variation in the cell lines used.
Cytotoxic effects of curcumin were time- and dose-dependent as it caused significant
reduction in cell viability of MDA-MB-231 at higher concentrations (30 and 10 ì g/ml) and
at different points of exposure (48 and 56 hours) (Fig. 1).  An increase in cell viability
indicates cell growth, while a drop in viability can be interpreted as a  result of either toxic
effects of compounds or suboptimal conditions.  It shows that the higher the concentration
of curcumin used and the longer it is exposed to the cells, the more toxic it will be.  Shao et
al. [8] reported that the cytotoxic effects of curcumin towards MDA-MB-231 appear to be
mediated through the downregulation of MMP-2 (matrix metalloproteinase) and the
upregulation of TIMP-1 (tissue inhibitor of metalloproteinase),  two common effector
molecules that have been implicated in regulating tumour cell invasion.
MDA-MB-231 cells treated with curcumin at concentrations of 30, 10 and 3 ì g/ml
rounded up, detached from the surface of the flask and shrunk.  They exhibited some
characteristics of apoptosis such as nuclear compaction, cytoplasmic constriction and
M 0 1 3 10 30ì g/ml
23 kbp
23 kbp
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reduction in cell volume, membrane blebbing, and formation of apoptotic bodies (Fig. 2).
The number of attached viable cells decreased with an  increase in  concentration of curcumin
(Figs. 2 and 3).  During apoptosis, cells initially round up and detach from the flask and their
neighbours with subsequent condensation of cytoplasm, dissolution of the nuclear envelope
and separation of the nucleus into distinct fragments, that ultimately brings to the collapse
of the cell into several small intact vesicles (apoptotic bodies).[9]   The remarkable phenotypic
alterations of apoptotic cells are caused by the destruction of the normal nuclear architecture
and cleavage of the chromatin during the cell demolishing process.  Collapse of the nucleus
is thought to be due to destabilisation of the nuclear envelope as a consequence of lamin
proteolysis.  This results in lost of the matrix attachment region-points at which the chromatin
is attached to the nuclear envelope, causing the chromatin to compact.[10]
The induction of apoptosis in the MDA-MB-231 cells was further confirmed at molecular
level by using the DNA fragmentation analysis.   After 24 hours, the DNA was intact.  A
ladder-like pattern of DNA was visible on agarose gel from the treatments of 30, 10 and 3 ì g/
ml of curcumin after 72 hours (Fig. 4).  The ladder-like pattern is one of the hallmarks of
apoptosis.[9]  The DNA fragmentation is caused by the activation of an endogenous nuclear
endonuclease, which selectively, distinctively, cleaves the double-stranded nuclear DNA
at sites located between nucleosomal units (linker DNA) generating mono- and oligo-
nucleosomal DNA fragments.  These DNA fragments reveal discrete multiples of an
approximately 180bp subunit.  The degraded DNA produces a so-called ladder-like pattern
when run on DNA agarose gel electrophoresis.[11, 12, 13, 14]  It has been suggested that DNA
digestion in apoptotic cells is an ordered process of multiple progression, which may involve
the collaborative action of a number of endonucleases and proteases, and that the nature of
the endonucleases activated may be cell type specific.[10]
CONCLUSION
Based on this study, it is concluded that curcumin is  cytotoxic in a dose- and time-dependent
manner to the human mammary carcinoma (MDA-MB-231) cells via an apoptosis-dependent
pathway.  Its action as inducer of apoptosis in the breast cancer cells suggests its potential
use as a strategy for  cancer control.  This is due to the fact that apoptosis is a discrete
manner of cell death that differs from necrotic cell death.  Apoptosis is always regarded as
an ideal way to destroy damaged cells, and an agent that can induce apoptosis is more
preferable for the management and therapy of cancer.
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